What is EYPT's health score?

EyePoint, Inc. (EYPT) has a TradeApes health score of 47 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is EYPT's estimated fair value?

Based on our 5-year discounted cash flow model, EyePoint, Inc.'s estimated fair value is $1940.03 per share, representing a 16368.9% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is EYPT undervalued or overvalued?

Our model currently rates EYPT as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for EYPT... Refresh in a moment for the full analysis.

EyePoint, Inc. (EYPT)

Healthcare Undervalued low mixed

$11.78

Updated: 2026-06-06

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

40 Weak

Relative Value

60 Healthy

Capital Allocation

30 Weak

Risk

50 Mixed

Est. Fair Value $1940.03

DCF Upside +16368.9%

Sector Rank #3799 of 6917

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.